NCT07237503Active, not recruiting
THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCER
Source: ClinicalTrials.gov · Last updated 19 Nov 2025
Brief summary (registry, in English)
Purpose: This study was carried out to investigate fatigue and exercise barriers of calisthenic exercises in patients with lung cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- First submitted
- 7 Jul 2025
- Start date
- 15 Jul 2025
- Primary completion date
- 1 Apr 2026
- Lead sponsor
- Hasan Kalyoncu University
- Diseases
- Lung cancer
- NCT number
- NCT07237503
What you commit to
- Study type: Interventional
- Planned participants: 33
- From 15 Jul 2025 to the primary completion date, 1 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Uncontrolled hypertension, diabetes mellitus, heart failure and atrial fibrillation
- Any acute infection at the time of assessment
Other
- Those with orthopaedic, neurological, psychological, etc. problems that may limit the assessments
Who the study is looking for
- To be between the ages of 18-65
- Patients with lung cancer who continue to receive chemotherapy, radiotherapy or immunotherapy (smart drugs)
- Patients reporting fatigue of 3 or more on the Modified Borg Scale
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hasan Kalyoncu Üniversitesi Coordinator of this site? Confirm its status | Gaziantep | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.